Nonetheless, despite the limitations of clinical interventions alone, efforts to reduce inequities in healthcare utilization and prescribing practices, along with improved screening and treatment options for APOL1-mediated kidney disease may contribute meaningfully to narrowing racial disparities in kidney disease among older adults. The gene discussed is APOL1; the disease is kidney disorder.